Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study
Abstract There are different methods of artificial liver support for patients with acute liver dysfunction (ALD). However, CytoSorb (CS) might be a new approved option for those patients. Question of interest is whether the elimination performance of CS was comparable to that of advanced organ suppo...
Guardado en:
Autores principales: | Christina Scharf, Uwe Liebchen, Michael Paal, Andrea Becker-Pennrich, Michael Irlbeck, Michael Zoller, Ines Schroeder |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c4393c897be42d1b332b1f8ee39c661 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
por: Uwe Liebchen, et al.
Publicado: (2021) -
Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib
por: Toshifumi Tada, et al.
Publicado: (2021) -
Albumin-Bilirubin Score for Prediction of Outcomes in Heart Failure Patients Treated with Cardiac Resynchronization Therapy
por: Shinya Yamada, et al.
Publicado: (2021) -
Elimination of fosfomycin during dialysis with the Genius system in septic patients
por: T. Dimski, et al.
Publicado: (2021) -
Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality
por: Naya Huang, et al.
Publicado: (2021)